Characteristics, phenotypes, mechanisms and management of severe asthma.
Chung KF, Dixey P, Abubakar-Waziri H, Bhavsar P, Patel PH, Guo S, Ji Y.
Chin Med J (Engl). 2022 May 20;135(10):1141-1155. doi: 10.1097/CM9.0000000000001990.
Classification of asthma.
Padem N, Saltoun C.
Allergy Asthma Proc. 2019 Nov 1;40(6):385-388. doi: 10.2500/aap.2019.40.4253.
Japanese guidelines for adult asthma 2020.
Nakamura Y, Tamaoki J, Nagase H, Yamaguchi M, Horiguchi T, Hozawa S, Ichinose M, Iwanaga T, Kondo R, Nagata M, Yokoyama A, Tohda Y; Japanese Society of Allergology.
Allergol Int. 2020 Oct;69(4):519-548. doi: 10.1016/j.alit.2020.08.001. Epub 2020 Sep 4.
The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma.
Nakagome K, Nagata M.
Biomolecules. 2024 May 2;14(5):546. doi: 10.3390/biom14050546.
Bronchial thermoplasty for severe asthma: potential mechanisms and response markers.
ChunXiao L, Xin H, Yun L, BoWen L, KunLu S, JiangTao L.
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241266348. doi: 10.1177/17534666241266348.
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].
Chinese Thoracic Society, Chinese Medical Association.
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
Asthma.
Lemanske RF Jr, Busse WW.
JAMA. 1997 Dec 10;278(22):1855-73.
Bronchial thermoplasty for severe asthma.
Thomson NC, Bicknell S, Chaudhuri R.
Curr Opin Allergy Clin Immunol. 2012 Jun;12(3):241-8. doi: 10.1097/ACI.0b013e32835335ca.
Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles.
Caminati M, Vatrella A, Rogliani P, Carpagnano E, Spanevello A, Senna G.
Respir Res. 2024 Oct 9;25(1):367. doi: 10.1186/s12931-024-02998-6.
Comparing bronchial thermoplasty with biologicals for severe asthma: Systematic review and network meta-analysis.
Fong KY, Zhao JJ, Syn NL, Nair P, Chan YH, Lee P.
Respir Med. 2023 Sep;216:107302. doi: 10.1016/j.rmed.2023.107302. Epub 2023 May 29.
